Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9421)
All Articles published online
|
Publishing Process of This Article
|
Oct 14, 2015 (publication date) through Nov 8, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ruta S, Cernescu C. Injecting drug use: A vector for the introduction of new hepatitis C virus genotypes. World J Gastroenterol 2015; 21(38): 10811-10823 [PMID: 26478672 DOI: 10.3748/wjg.v21.i38.10811] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v21/i38/10811.htm |
| Number | Citing Articles |
| 1 |
Ying Chen, Changshun Yu, Xueru Yin, Xiaolei Guo, Shangwei Wu, Jinlin Hou. Hepatitis C virus genotypes and subtypes circulating in Mainland China. Emerging Microbes & Infections 2017; 6(1): 1 doi: 10.1038/emi.2017.77
|
| 2 |
Joseph Bick, Gabriel Culbert, Haider A. Al-Darraji, Clayton Koh, Veena Pillai, Adeeba Kamarulzaman, Frederick Altice. Healthcare resources are inadequate to address the burden of illness among HIV-infected male prisoners in Malaysia. International Journal of Prisoner Health 2016; 12(4): 253 doi: 10.1108/IJPH-06-2016-0017
|
| 3 |
Carmen L. Loureiro, Rossana C. Jaspe, Flor H. Pujol. Variation in Hepatitis C Virus Subtype Distribution during 20 Years in Venezuela. Intervirology 2019; 62(5-6): 191 doi: 10.1159/000505065
|
| 4 |
Anissa Chouikha, Amine Ghrabi, Amira Ghodbane, Walid Hammemi, Marwa Khedhiri, Amel Sadraoui, Henda Touzi, Hichem Ben Hassine, Sonia Maatoug, Chaima Bensaoud, Sonia Abdelhak, Samir Bouarrouj, Mariem Gdoura, Hedia Chaouachi, Henda Triki. Distribution of HCV Genotypes Among People Who Inject Drugs in Tunisia: New Evidence for Scaling Up Prevention and Treatment Toward National Elimination Goal. Frontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.697859
|
| 5 |
Hafsa Aziz, Shazia Fatima, Mohammad Faheem. Indeterminate Prediction of Hepatitis C Virus Genotype by Commercial Real-Time Polymerase Chain Reaction Assay Resolving by Sequencing to Avoid the Consequence of Inaccurate Typing. Viral Immunology 2020; 33(7): 507 doi: 10.1089/vim.2019.0162
|
| 6 |
Marcello Persico, Andrea Aglitti, Michele Milella, Carmine Coppola, Vincenzo Messina, Ernesto Claar, Ivan Gentile, Fernando Sogari, Paola Pierri, Lorenzo A. Surace, Filomena Morisco, Paolo Tundo, Giuseppina Brancaccio, Gaetano Serviddio, Pietro Gatti, Antonio P. Termite, Giovan G. Di Costanzo, Benedetto Caroleo, Raffaele Cozzolongo, Nicola Coppola, Annamaria Longo, Luca Fontanella, Alessandro Federico, Valerio Rosato, Irene Terrenato, Mario Masarone. Real‐life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL study. Liver International 2019; 39(10): 1852 doi: 10.1111/liv.14170
|
| 7 |
Yadollah Mehrabi, Koorosh Etemad, Alireza Noroozi, Peter Higgs, Maryam Nasirian, Asaad Sharhani, Nahid Khademi, Ahmad Hajebi, Mehdi Noroozi, Ebrahim Shakiba, Behrooz Hamzeh, Mehdi Azizmohammad Looha. Correlates of injecting paraphernalia sharing among male drug injectors in Kermanshah, Iran: implications for HCV prevention. Journal of Substance Use 2020; 25(3): 330 doi: 10.1080/14659891.2019.1698670
|
| 8 |
Nicola Coppola, Carmine Minichini, Mario Starace, Caterina Sagnelli, Evangelista Sagnelli. Clinical impact of the hepatitis C virus mutations in the era of directly acting antivirals. Journal of Medical Virology 2016; 88(10): 1659 doi: 10.1002/jmv.24527
|
| 9 |
Sevin Kirdar, Neriman Aydin, Yasin Tiryaki, Bulent Ertugrul, Adil Coskun, Mehmet Bilgen. Dynamics of HCV epidemiology in Aydin province of Turkey and the associated factors. APMIS 2018; 126(2): 109 doi: 10.1111/apm.12790
|
| 10 |
Debashis Chowdhury. Hepatitis C: approaching a global problem from a Canadian perspective. Liver Research, Disorders & Therapy 2018; 4(2) doi: 10.15406/jlrdt.2018.04.00105
|
| 11 |
Michael Fichter, Keti Piradashvili, Anette Pietrzak-Nguyen, Leah Pretsch, Gabor Kuhn, Susanne Strand, Markus Knuf, Fred Zepp, Frederik R. Wurm, Volker Mailänder, Katharina Landfester, Stephan Gehring. Polymeric hepatitis C virus non-structural protein 5A nanocapsules induce intrahepatic antigen-specific immune responses. Biomaterials 2016; 108: 1 doi: 10.1016/j.biomaterials.2016.08.046
|
| 12 |
Evangelista Sagnelli, Mario Starace, Carmine Minichini, Mariantonietta Pisaturo, Margherita Macera, Caterina Sagnelli, Nicola Coppola. Resistance detection and re-treatment options in hepatitis C virus-related chronic liver diseases after DAA-treatment failure. Infection 2018; 46(6): 761 doi: 10.1007/s15010-018-1188-3
|
| 13 |
Tahereh Donyavi, Farah Bokharaei-Salim, Khadijeh Khanaliha, Maryam Sheikh, Mohammad-Navid Bastani, Najmeh Moradi, Roghayeh Babaei, Zahra Habib, Atousa Fakhim, Maryam Esghaei. High prevalence of occult hepatitis C virus infection in injection drug users with HIV infection. Archives of Virology 2019; 164(10): 2493 doi: 10.1007/s00705-019-04353-3
|
| 14 |
Ruth M. Lunn, Gloria D. Jahnke, Charles S. Rabkin. Tumour virus epidemiology. Philosophical Transactions of the Royal Society B: Biological Sciences 2017; 372(1732): 20160266 doi: 10.1098/rstb.2016.0266
|
| 15 |
BENJAMIN CHIN‐YEE, S.V. SUBRAMANIAN, AMOL A. VERMA, ANDREAS LAUPACIS, FAHAD RAZAK. Emerging Trends in Clinical Research With Implications for Population Health and Health Policy. The Milbank Quarterly 2018; 96(2): 369 doi: 10.1111/1468-0009.12328
|
| 16 |
Kamyar Arasteh, Don C. Des Jarlais, Jonathan Feelemyer, Courtney McKnight. Hepatitis C incidence and prevalence among Puerto Rican people who use drugs in New York City. Global Public Health 2020; 15(12): 1789 doi: 10.1080/17441692.2020.1768276
|
| 17 |
Cong Liu, Yi-lei Ma, Xue-han Liu, Yan-ran Duan, Pu-lin Liu, Xia Wang, Ping Yin. Sociodemographic Factors Associated With HIV/HCV High-Risk Behaviors Among People Who Use Drugs on Methadone Maintenance Treatment: A 10-Year Observational Study. Frontiers in Psychiatry 2021; 12 doi: 10.3389/fpsyt.2021.707257
|
| 18 |
Nesrin Dilbaz, Murat Kuloğlu, Ekrem Cuneyt Evren, Salih Cihat Paltun, Rabia Bilici, Cemal Onur Noyan, Burak Kulaksizoglu, Vahap Karabulut, Gokhan Umut, Basak Unubol, Enver Ucbilek. HCV Genotype Distribution Among People Who Inject Drug in Turkey: Findings from Multicenter and Cross-Sectional Study. Substance Abuse: Research and Treatment 2023; 17 doi: 10.1177/11782218231157340
|
| 19 |
Matthew J. Akiyama, Abbe Muller, Owen Huang, John Lizcano, Mercy Nyakowa, Lindsey Riback, Jonathan Ross, Henry Bundi, Euphrasia Shitachi Kulabi, Ann Muthoni Mwangi, Helgar Musyoki, Peter Cherutich, Ann Kurth. Hepatitis C-related knowledge, attitudes and perceived risk behaviours among people who inject drugs in Kenya: A qualitative study. Global Public Health 2022; 17(6): 1016 doi: 10.1080/17441692.2021.1896763
|
| 20 |
Xiaozhong Wang, Lai Wei. Direct-acting Antiviral Regimens for Patients with Chronic Infection of Hepatitis C Virus Genotype 3 in China. Journal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2020.00097
|
| 21 |
Francesco Foschi, Alberto Borghi, Alberto Grassi, Arianna Lanzi, Elvira Speranza, Teo Vignoli, Lucia Napoli, Deanna Olivoni, Michele Sanza, Edoardo Polidori, Giovanni Greco, Paolo Bassi, Francesco Cristini, Giorgio Ballardini, Mattia Altini, Fabio Conti. Model of Care for Microelimination of Hepatitis C Virus Infection among People Who Inject Drugs. Journal of Clinical Medicine 2021; 10(17): 4001 doi: 10.3390/jcm10174001
|
| 22 |
Virginia Sedeño-Monge, Saul Laguna-Meraz, Gerardo Santos-López, Arturo Panduro, Francisca Sosa-Jurado, Alexis Jose-Abrego, Daniel Meléndez-Mena, Marco A. Muñoz-Ramírez, Monserrat Cosme-Chávez, Sonia Roman. A comprehensive update of the status of hepatitis C virus (HCV) infection in Mexico—A systematic review and meta-analysis (2008–2019). Annals of Hepatology 2021; 20: 100292 doi: 10.1016/j.aohep.2020.100292
|
| 23 |
Onyema Ogbuagu, Gerald Friedland, R. Douglas Bruce. Drug interactions between buprenorphine, methadone and hepatitis C therapeutics. Expert Opinion on Drug Metabolism & Toxicology 2016; 12(7): 721 doi: 10.1080/17425255.2016.1183644
|
| 24 |
Carlos Roncero, Richard Littlewood, Pablo Vega, Jose Martinez-Raga, Marta Torrens. Chronic hepatitis C and individuals with a history of injecting drugs in Spain: population assessment, challenges for successful treatment. European Journal of Gastroenterology & Hepatology 2017; 29(6): 629 doi: 10.1097/MEG.0000000000000855
|
| 25 |
Jing Lu, Li Zhang, Xiaoqin Xu, Yuanfang Chen, Ying Zhou, Zhi Zhang, Gengfeng Fu, Guohong Chen. Hepatitis C virus genotype diversity and distribution among methadone maintenance treatment patients in Jiangsu, China. Drug and Alcohol Dependence 2019; 194: 101 doi: 10.1016/j.drugalcdep.2018.09.026
|
| 26 |
Matías J. Pereson, Alfredo P. Martínez, Katia Isaac, Gustavo Laham, Ezequiel Ridruejo, Gabriel H. Garcia, Diego M. Flichman, Federico A. Di Lello. Seroprevalence of hepatitis B, hepatitis C and HIV infection among patients undergoing haemodialysis in Buenos Aires, Argentina.
Journal of Medical Microbiology
2021; 70(1) doi: 10.1099/jmm.0.001278
|
| 27 |
Lorenzo Onorato, Mariantonietta Pisaturo, Mario Starace, Carmine Minichini, Alessandra Di Fraia, Roberta Astorri, Nicola Coppola. Virological Factors Associated with Failure to the Latest Generation of Direct Acting Agents (DAA) and Re-Treatment Strategy: A Narrative Review. Viruses 2021; 13(3): 432 doi: 10.3390/v13030432
|
| 28 |
Asaad Sharhani, Yadollah Mehrabi, Alireza Noroozi, Maryam Nasirian, Peter Higgs, Ahmad Hajebi, Behrooz Hamzeh, Nahid Khademi, Mehdi Noroozi, Ebrahim Shakiba, Koorosh Etemad. Hepatitis C Virus Seroprevalence and Associated Risk Factors Among Male Drug Injectors in Kermanshah, Iran. Hepatitis Monthly 2017; 17(10) doi: 10.5812/hepatmon.58739
|
| 29 |
Matthew J Akiyama, Lindsey Riback, Jacqueline D Reeves, Yolanda S Lie, Linda Agyemang, Brianna L Norton, Julia H Arnsten, Alain H Litwin. Hepatitis C Resistance-Associated Substitutions Among People Who Inject Drugs Treated With Direct-Acting Antiviral-Containing Regimens. Open Forum Infectious Diseases 2021; 8(10) doi: 10.1093/ofid/ofab474
|
| 30 |
Qiao Tang, Zhiwei Chen, Hu Li, Li Zhang, Mingli Peng, Yi Zeng, Xiaoqing Liu, Zubi Liu, Peng Hu. Molecular epidemiology of hepatitis C virus genotypes in different geographical regions of Chinese mainland and a phylogenetic analysis. Infectious Diseases of Poverty 2023; 12(1) doi: 10.1186/s40249-023-01106-y
|
| 31 |
Tsung-Lung Tsai, Huei-Min Jhou, Frank S Fan. Conspicuous Response to Direct-Acting Antivirals in Chronic Hepatitis C-related Immune Thrombocytopenia: A Case Report. Cureus 2022; doi: 10.7759/cureus.24193
|
| 32 |
Rachel M. Murdock, Marisa B. Brizzi, Omar Perez, Melissa E. Badowski. Public Health Considerations among People who Inject Drugs with HIV/HCV Co-Infection: A Review. Infectious Diseases and Therapy 2019; 8(1): 23 doi: 10.1007/s40121-018-0228-8
|
| 33 |
Erick Joan Vidal-Alcántara, Sonia Hernández Antón, Paloma Rueda, María Belén Yélamos, Julián Gómez, Salvador Resino, Alba Fresco-Taboada, Isidoro Martínez. Development of a Lateral Flow Assay for the Detection of the Hepatitis C Virus Core Antigen. Pharmaceuticals 2024; 17(8): 1022 doi: 10.3390/ph17081022
|
| 34 |
Angélique Ndjoyi-Mbiguino, Arnaud John Kombe Kombe, Berthold Bivigou-Mboumba, Samira Zoa-Assoumou, Falone Larissa Akombi, Francis Nzengui Nzengui, Hervé M’boyis Kamdem, Sandrine François-Souquière, Jason Blackard. Low prevalence of HCV infection with predominance of genotype 4 among HIV patients living in Libreville, Gabon. PLOS ONE 2018; 13(1): e0190529 doi: 10.1371/journal.pone.0190529
|
| 35 |
Mohamed A Daw, Abdallah A El-Bouzedi, Mohamed O Ahmed, Aghnyia A Dau, Mohamed M Agnan, Aisha M Drah. Geographic integration of hepatitis C virus: A global threat. World Journal of Virology 2016; 5(4): 170-182 doi: 10.5501/wjv.v5.i4.170
|
| 36 |
Mohamed A. Daw, Abdallah El-Bouzedi, Mohamed O. Ahmed, Aghnyia A. Dau, Mohamed M. Agnan. Epidemiology of hepatitis C virus and genotype distribution in immigrants crossing to Europe from North and sub-Saharan Africa. Travel Medicine and Infectious Disease 2016; 14(5): 517 doi: 10.1016/j.tmaid.2016.05.020
|
| 37 |
Ahmed Abdel Aziz. Hepatitis C in Developing Countries. 2018; : 3 doi: 10.1016/B978-0-12-803233-6.00001-1
|
| 38 |
Wim Schuermans, Hans Orlent, Isabelle Desombere, Patrick Descheemaeker, Hans Van Vlierberghe, Anja Geerts, Xavier Verhelst, Marijke Reynders, Elizaveta Padalko. Heads or Tails: Genotyping of Hepatitis C Virus Concerning the 2k/1b Circulating Recombinant Form. International Journal of Molecular Sciences 2016; 17(9): 1384 doi: 10.3390/ijms17091384
|